Anti-Diabetic Pharmaceuticals Market in India 2012
- Language: English
- 76 Pages
- Published: March 2012
- Region: India
- Your are here:
- Home
- Categories
- Pharmaceuticals and Healthcare
- Pharmaceuticals
- Oncology
Oncology Pharmaceuticals Market in India 2012
Oncology Pharmaceuticals Market in India 2012
- Published: April 2012
- Region: India
- 71 Pages
- Netscribes (India) Pvt Ltd
FEATURED COMPANIES
- Aventis Pharma Limited
- Cipla Limited
- Merck Limited
- Novartis India Limited
- Pfizer Limited
- MORE
Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially in lung cancer and breast cancer cases; changes in the cancer treatment scenario, development of alternative cancer therapies, increased cancer health insurance coverage and increasing amount of foreign direct investment (FDI) is helping the market to grow. The Indian Government, on its part is taking initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. The market is expected to exhibit steady growth over the next few years.
The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export
READ MORE >
Page 1: Executive summary
Market Overview
Page 2: Global Oncology Pharmaceuticals Market – Overview, Size & Growth (Value: 2007 and 2013e),
Page 3: Indian Oncology Pharmaceuticals Market- Overview, Size & Growth (Value: 2010-2016e)
Page 4: Overview of cancer prevalence in India
Page 5-6: EXIM statistics of oncology pharmaceuticals (Value: 2006-07 to 2010-11)
Drivers & Challenges
Page 7: Summary
Page 8-12: Drivers
Page 13-15: Challenges
Government Initiatives
Page 16: Summary
Page 12- 21: Government Initiatives
Market value chain, regulation and patents
Page 22: Pharmaceutical value chain
Page 23: Phases of clinical trials
Page 24: Indian government functions in licensing and registration of pharmaceuticals
Page 25: Indian drug regulatory frameworks
Page 26- 27: List of patent approvals by US FDA
Page 28: List of oncology drug marketing approvals in India
Competition
Page 29: Market Competition – Porter’s Five Forces Analysis
Page 30- 63: Major public players
Page 58- 69: Major private players
Page 70: Recent Developments
Strategic Recommendation
Page 71: Strategic Recommendations
- Aventis Pharma Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Fresenius Kabi Oncology Limited
- GlaxoSmithKline Pharmaceuticals Limited
- Novartis India Limited
- Merck Limited
- Pfizer Limited
- Ranbaxy Laboratories Limited
- Sun Pharmaceutical Industries Limited
- Cytogen Pharmaceuticals India Private Limited
- Johnson and Johnson Limited
- Roche Pharmaceuticals Private Limited
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
- Published: January 2011
FROM -
Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)
- Language: English
- 286 Pages
- Published: November 2011
- Region: World
FROM -
Global Biosimilars Market - Products, Applications and Regulations
- Language: English
- 354 Pages
- Published: November 2012
- Region: World
FROM -
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
- Language: English
- 108 Pages
- Published: August 2011
- Region: India
FROM -
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth
- Language: English
- 82 Pages
- Published: October 2012
- Region: China, India, South Korea
FROM -
Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment
- Language: English
- 94 Pages
- Published: January 2013
- Region: India
FROM -
Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth
- Language: English
- 74 Pages
- Published: January 2013
- Region: India
FROM -
Oncology Pharmaceuticals Market in India 2011
- Language: English
- 41 Pages
- Published: August 2011
- Region: India
FROM -
Pharmaceutical Market India: A Comprehensive Industry Analysis
- Language: English
- 161 Pages
- Published: May 2013
- Region: India
FROM
